Abstract

Estrogen and androgen deficiency have been associated with the incidence of osteoporosis in postmenopausal women and elderly men over the last many decades. Estrogen and androgen function through signaling pathways that originate from binding to their cognate nuclear receptors, which collectively impact sexual function, growth and development, and skeletal health. These effects range from gain-of-function paradigms involving their cognate ligands that target these nuclear hormone receptor-mediated signaling pathways to loss-of-function paradigms that involve menopause/aging or rare allelic variants that abrogate ligand or receptor function. This review summarizes our current knowledge of the gain-of-function and loss-of-function attributes of these two steroid hormones with specific emphasis on androgens and male skeletal health.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.